Nasdaq:US$13.41 (-0.23) | HKEX:HK$21.30 (+0.15) | AIM:£2.15 (-0.07)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 6 Apr 2011

AACR 2011: Savolitinib (HMPL-504) against subcutaneous xenograft and orthotopic brain tumor models